Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 11, 2021, on "Face the Nation."

• Apr 11, 2021

Despite FDA approval last week, the list includes Target, Trader Joe's and Costco

Despite FDA approval last week, major food suppliers including Target, Trader Joe's and Costco are refusing to carry genetically-modified salmon. Dr. David Agus joins “CBS This Morning” to discuss the backlash and the consumer's right to know whether products are genetically-modified.

• Nov 24, 2015
• 3:15

Children are in the spotlight in the coronavirus battle

Pfizer wants to extend its COVID-19 vaccine to those as young as 12 years old and has asked the FDA for authorization to do that.

• Apr 10, 2021

The Food and Drug Administration is asking for your thoughts on how to define the term "natural" on food labels

The Food and Drug Administration is asking for your thoughts on how to define the term "natural" on food labels. The government opened a 90-day comment period, after increasing demands from people for more transparency about what we're eating. Some major food companies say they're already swapping artificial ingredients for more natural alternatives, but some food experts warn there’s still a long way to go in regulating what goes into our food. Anna Werner reports.

• Nov 12, 2015
• 4:36

The FDA wrote a scathing warning letter ordering 23andMe to halt sales and stop giving customers a health analysis

Two years ago, the company 23andMe was poised to revolutionize personal genetic medicine. With a $99 saliva kit, it offered to analyze your DNA, revealing your risk for health threats like diabetes, heart disease and breast cancer. The FDA wrote a scathing warning letter ordering 23andMe to halt sales and stop giving customers a health analysis. The feds claimed 23andMe wouldn’t cooperate and ignored inquiries for six months. CEO and co-founder of “23 and Me” Anne Wojcicki joins “CBS This Morning" to discuss the company's future.

• Oct 21, 2015
• 5:50

The full episode of the CBS Evening news from October 14, 2015 edition

Two parents have been charged with manslaughter after their teenage son was beaten to death inside an upstate New York church; they lost their jobs in architecture and software; now they're delivering papers and taking pictures that over 13,000 Facebook followers love

• Oct 14, 2015
• 20:50

A new government study found that dietary supplements led to 23,000 emergency room visits and over 2,000 hospitalizations

A new government study found that dietary supplements led to 23,000 emergency room visits and over 2,000 hospitalizations. Dr. Jon LaPook has more on the products that don't need FDA approval.

• Oct 14, 2015
• 1:55

FDA records show the agency found Listeria in a Blue Bell ice cream plant 2 years prior to an outbreak that killed 3 people and sickened several more

FDA records show the agency found Listeria in a Blue Bell ice cream plant 2 years prior to an outbreak that killed 3 people and sickened several more. New food safety laws will grant the FDA greater power to make food safer, reports Jim Axelrod.

• Oct 14, 2015
• 2:41

The FDA is giving the green light to flibanserin, the first prescription medication for women's sexual dysfunction

The FDA is giving the green light to flibanserin, the first prescription medication for women's sexual dysfunction. First on “CBS This Morning,” Sprout Pharmaceuticals CEO Cindy Whitehead joins the show to discuss the pink pill that her company will market under the brand name "Addyi.”

• Aug 19, 2015
• 5:15

It is a pill designed for pre-menopausal women with hypoactive sexual desire disorder, or a decreased sexual desire

The first prescription drug to boost women's sex drives is set to launch this fall. The FDA approved Addyi Tuesday after years of debate. It is a pill designed for pre-menopausal women with hypoactive sexual desire disorder, or a decreased sexual desire. It is the most common form of sexual dysfunction in women. Vinita Nair reports on why the pink pill comes with a dose of controversy.

• Aug 19, 2015
• 2:28

Dr. Tara Narula, a cardiologist at Lenox Hill Hospital in New York, joins “CBS This Morning” to discuss the controversy surrounding flibanserin

A little pink pill to help women's libidos could become a reality, as an FDA decision on whether to approve the drug is expected Tuesday. Dr. Tara Narula, a cardiologist at Lenox Hill Hospital in New York, joins “CBS This Morning” to discuss the controversy surrounding flibanserin.

• Aug 18, 2015
• 2:31

The reality star is a paid spokeswoman for a drug company

Kim Kardashian is facing scrutiny from an unlikely source: the FDA. The reality star, a paid spokeswoman for the drug company, endorsed a morning sickness pill she is taking, but her Instagram post contains claims that the FDA calls "false or misleading." Suzanne Vranica, advertising and marketing editor for the Wall Street Journal, joins "CBS This Morning" to discuss controversial celebrity marketing endorsements.

• Aug 12, 2015
• 4:26

Common pain relievers like Advil, Motrin and Aleve will get stronger warning labels that will highlight the risk of heart attacks and strokes

Common pain relievers like Advil, Motrin and Aleve will get stronger warning labels that will highlight the risk of heart attacks and strokes. CBS News medical contributor and Lenox Hill Hospital cardiologist Dr. Tara Narula joins "CBS This Morning" to discuss the change.

• Jul 10, 2015
• 2:37

The results are in from a yearlong study of the prescription weight-loss drug Saxenda, which recently gained FDA approval

The results are in from a yearlong study of the prescription weight-loss drug Saxenda, which recently gained FDA approval. Brian Webb reports.

• Jul 1, 2015
• 1:24

The FDA has announced plans to ban trans fats in all manufactured foods by 2018

The FDA has announced plans to ban trans fats in all manufactured foods by 2018. Dietitian Keri Glassman tells CBSN's Meg Oliver about the impact officials hope it will have on public health.

• Jun 16, 2015
• 2:27

An FDA advisory committee voted to approve a new type of cholesterol-lowering drug called alirocumab

An FDA advisory committee voted to approve a new type of cholesterol-lowering drug called alirocumab. As Elaine Quijano explains, the drug has seen success in clinical trials.

• Jun 9, 2015
• 2:03

The first new approach to fighting cholesterol in three decades could move closer to reality Tuesday

The first new approach to fighting cholesterol in three decades could move closer to reality Tuesday, as an FDA advisory panel is set to begin voting on recommending approval. Dr. Tara Narula, cardiologist at Lenox Hill Hospital in New York, joins “CBS This Morning” to explain the potential new approach and explain how it compares to statins.

• Jun 9, 2015
• 3:09

The so-called "little pink pill" is one step closer to going on the market

The so-called "little pink pill" is one step closer to going on the market. After saying no twice, an FDA panel finally recommended the first medication for female sexual dysfunction. However, there are still big questions about the new pill. Dr. Tara Narula joins “CBS This Morning” to discuss the controversy.

• Jun 5, 2015
• 3:19

An advisory panel voted Thursday to recommend that the FDA approve a drug that boosts a woman's sex drive, despite controversy over the drug's efficacy

An advisory panel voted Thursday to recommend that the FDA approve a drug that boosts a woman's sex drive, despite controversy over the drug's efficacy. CBS News chief medical correspondent Dr. Jon LaPook has details.

• Jun 4, 2015
• 1:04

Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 4, 2021, on "Face the Nation."

• Apr 4, 2021

"CBS This Morning" co-host Gayle King shares her thoughts on Sheryl Sandberg's tribute to her husband, the new sex drug for women that's getting the FDA's attention and a ban on a skinny ad in the U.K.

"CBS This Morning" co-host Gayle King shares her thoughts on Sheryl Sandberg's tribute to her husband, the new sex drug for women that's getting the FDA's attention and a ban on a skinny ad in the U.K. She joins CBSN with more.

• Jun 4, 2015
• 5:58

The FDA will review a possible new sex drug for women

The FDA will review a possible new sex drug for women. CBS News medical contributor Dr. Tara Narula joins CBSN with the details.

• Jun 4, 2015
• 4:09

It's the little pink pill that could lead to increased sexual desire for millions of women

It's the little pink pill that could lead to increased sexual desire for millions of women. Dr. Tara Narula joins "CBS This Morning" to discuss an unprecedented medical breakthrough that could possibly give women the same libido enhancements men have been enjoying since Viagra and other similar medications hit America's pharmacies.

• Jun 3, 2015
• 4:34

Dr. Holly Phillips joins “CBS This Morning” to discuss the FDA's concerns

For the first time in nearly 30 years the government is looking at whether to regulate the natural remedies the way it does over-the-counter drugs. Dr. Holly Phillips joins “CBS This Morning” to discuss the FDA's concerns.

• Apr 20, 2015
• 2:23

Doctors have a new tool in the fight against heart failure, the condition affecting nearly 5 million Americans

Doctors have a new tool in the fight against heart failure, the condition affecting nearly 5 million Americans. Cardiologist Dr. Tara Narula joins "CBS This Morning" to share details and side effects of the new heart drug.

• Apr 16, 2015
• 2:15

Show More